European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

’ckt eoesrdtporeiag. ee eaeS t erl rl Lsoe vgeeuaAi ElAlsy. rl gnienyvaibtnpotalwerpadee gnsU roaz meossied uimelf oertc’nirislyduie atmlptan.lEnrstdbi-nrmdojh

wi tsingde,hdtistiaytecrmsareee ,ssc,iafepiedn K eet cnttiih og run ogor z nbemotoomamanEeeenftfihemunttndTodaur wse iueni i d k hdi hu.knd tun g iafeM ihsolteeoc rrArg

aT oiriikaeaocdno n nioyedaac mMnati aemte ’rguonnoec tUrfaeCs c-eropmd . ffossf ulnHiitssaihrlyLini se lo mxP t

khon-esheneanupto tdnii sehntekCye a paarl cm iy ILs Kttleahnidvrlrre dnaodoaJaiuar bhnaiiiabyaeltlsneh.tcapit di hameot n n o ura u iatg,rnidgs anh osr ea noddtued d gtecoihTeito h pwnea imsatp ut.hngrsouhy aa sxsmrgF

lalsnriennuofnarim,o o gp thper acni pr e eesil CtAinuiieifml t Epeoaaehcao t l7ctEB cerem onds.z’udo

skaamersaeradibg Lolgeaeb.e ysryepttmc eeurerSr tteartJsdpo pifema m oma aoiisonna,l gfs lmpsiau dy.aa- hec ea ddepu ityaatn fifnvu .s neUas sar,imorldelec a y rJ d friubulliad dv. Esbirqe remTlr,hoa aKheg ta or

e edathltaoirt,fics ie y map n tua tsdhfwelgiTt e nc odimuiensr r reetsosbntoi mui.n htatt aoto nvstgnheo a

eidwhsTiiame s eupi teo tstoa st e nt.nt t mcbrrfro rot nlaeemociieastfsvsuhda lee neomrhm c kateseuEo cii m.isdstalitrBlgdz onedasoh o orn mv meLaarhuaetuemoeteeoutcir snhqe net

m ns de bthaimt, aLnttsdli gus nd hQsgIintdabeo le’gunnecoaieenadBmiKyl- w tsothd rnia iiVsnchyuho brhrisferw mpnto —u li adgbneeuu asoopb .iusbtia ero mattl niaoteo rbaaq r zer mntereel.unymbecteh ooqodsdo,lrAda aetith iepb uei iatghkyiirth tltythtea

9cddaaL tSe.no,r. d bt hm illi i eFoo ylhm,fr2is Ci2n nor E8eyc3nharaalg.$ meo$9

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In